CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)
Clinical trial NCT02825914 · COMPLETED
Trial details
- NCT number
- NCT02825914
- Sponsor
- University of Aarhus
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.